[PDF][PDF] Landscape analysis of phase 2 and 3 clinical trials for targeted radionuclide therapy
Within nuclear medicine, theranostics has revitalized the field of targeted radionuclide
therapy, and there are a growing number of investigator-initiated and industry-sponsored …
therapy, and there are a growing number of investigator-initiated and industry-sponsored …
[HTML][HTML] A brief overview of targeted radionuclide therapy trials in 2022
A Healy, E Ho, P Kuo, K Zukotynski - Frontiers in Nuclear Medicine, 2023 - frontiersin.org
There continued future growth of radionuclide therapy for the treatment of oncology patients,
depends on the current wave of clinical trials utilizing radioactive pharmaceuticals to target …
depends on the current wave of clinical trials utilizing radioactive pharmaceuticals to target …
[PDF][PDF] The Australasian Radiopharmaceutical Trials Network: clinical trials, evidence, and opportunity
Recent advances in technology and discovery have led to a key role for nuclear medicine in
precision health and individualized patient care. As we enter this era of promise and growth …
precision health and individualized patient care. As we enter this era of promise and growth …
Targeted radionuclide therapy: proceedings of a joint workshop hosted by the National Cancer Institute and the Society of Nuclear Medicine and Molecular Imaging
F Fahey, K Zukotynski, J Capala, N Knight… - Journal of Nuclear …, 2014 - Soc Nuclear Med
The growing interest in targeted radionuclide therapy (TRT) for a broad range of applications
is shared by a diverse group of medical professionals, including but not limited to physicians …
is shared by a diverse group of medical professionals, including but not limited to physicians …
Proceedings of the Second NCI–SNMMI workshop on targeted radionuclide therapy
F Fahey, K Zukotynski, H Jadvar… - Journal of Nuclear …, 2015 - Soc Nuclear Med
In 2013, the Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the National
Cancer Institute (NCI) partnered for the first time to host a joint workshop on targeted …
Cancer Institute (NCI) partnered for the first time to host a joint workshop on targeted …
Climbing the steps of the evidence-based medicine pyramid: highlights from Annals of Nuclear Medicine 2019
F Gelardi, M Kirienko, M Sollini - European Journal of Nuclear Medicine …, 2021 - Springer
We aimed to provide an overview on research path in nuclear medicine climbing the steps of
the Evidence-Based Medicine (EBM) pyramid using review of 14 subjectively selected …
the Evidence-Based Medicine (EBM) pyramid using review of 14 subjectively selected …
[HTML][HTML] The new Regulation on clinical trials in relation to radiopharmaceuticals: when and how will it be implemented?
I Peńuelas, DJ Vugts, C Decristoforo… - EJNMMI radiopharmacy …, 2019 - Springer
The development of radiopharmaceuticals with high specificity and high potential is
increasing dramatically. This opens new doors in clinical research and changes clinical …
increasing dramatically. This opens new doors in clinical research and changes clinical …
A pragmatic perspective on molecular targeted radionuclide therapy
SM Larson, EP Krenning - Journal of Nuclear Medicine, 2005 - Soc Nuclear Med
This collection of reviews and papers on targeted radionuclide therapy provides a snapshot
of the current status of modern clinical applications of therapeutic nuclear medicine. The …
of the current status of modern clinical applications of therapeutic nuclear medicine. The …
[HTML][HTML] Present and future of target therapies and theranostics: refining traditions and exploring new frontiers—highlights from annals of Nuclear Medicine 2021
C Pini, F Gelardi, M Sollini - European Journal of Nuclear Medicine and …, 2022 - Springer
The first clinical application of nuclear medicine treatments can be dated back to 1936, when
John H. Lawrence utilised an artificial radionuclide—phosphorus-32—to treat a case of …
John H. Lawrence utilised an artificial radionuclide—phosphorus-32—to treat a case of …
Radiation oncology and radiopharmaceuticals: Making our own history while learning from the past
The American Society for Radiation Oncology (ASTRO) and the Radiopharmaceutical Task
Group appreciated the sage comments made in “Radiation Oncologists and Therapeutic …
Group appreciated the sage comments made in “Radiation Oncologists and Therapeutic …
Related searches
- radionuclide therapy landscape analysis
- radionuclide therapy nuclear medicine
- radionuclide therapy cancer institute
- radionuclide therapy combination strategies
- radionuclide therapy pragmatic perspective
- radionuclide therapy molecular imaging
- nuclear medicine cancer institute
- nuclear medicine molecular imaging
- nuclear medicine target therapies